Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 31951 - 31975 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cisplatin	Approved Investigational	PSAT1	29968	upregulated	Cisplatin results in increased expression of PSAT1 mRNA	9q21.2	A20427
Cisplatin	Approved Investigational	PSD3	23362	downregulated	Cisplatin results in decreased expression of PSD3 mRNA	8p22	A22204
Cisplatin	Approved Investigational	PSMB10	5699	upregulated	Cisplatin results in increased expression of PSMB10 mRNA	16q22.1	A22208
Cisplatin	Approved Investigational	PSMB9	5698	upregulated	Cisplatin results in increased expression of PSMB9 mRNA	6p21.32	A22208
Cisplatin	Approved Investigational	PSMC3IP	29893	downregulated	Cisplatin results in decreased expression of PSMC3IP mRNA	17q21.2	A21499
Cisplatin	Approved Investigational	PTEN	5728	downregulated	[MIR21 mRNA results in decreased susceptibility to Cisplatin] which results in decreased expression of PTEN mRNA	10q23.31	A22257
Cisplatin	Approved Investigational	PTGS2	5743	upregulated	Cisplatin results in increased expression of PTGS2 mRNA	1q31.1	A22259
Cisplatin	Approved Investigational	PTK2	5747	downregulated	Cisplatin results in decreased expression of PTK2 mRNA	8q24.3	A22204 A22212
Cisplatin	Approved Investigational	PTP4A1	7803	downregulated	Cisplatin results in decreased expression of PTP4A1 mRNA	6q12	A21499
Cisplatin	Approved Investigational	PTPN14	5784	downregulated	Cisplatin results in decreased expression of PTPN14 mRNA	1q32.3-q41	A22211
Cisplatin	Approved Investigational	PTPRK	5796	downregulated	Cisplatin results in decreased expression of PTPRK mRNA	6q22.33	A22204 A22203
Cisplatin	Approved Investigational	PUS3	83480	downregulated	Cisplatin results in decreased expression of PUS3 mRNA	11q24.2	A21499
Cisplatin	Approved Investigational	PUS3	83480	upregulated	Cisplatin results in increased expression of PUS3 mRNA	11q24.2	A22204
Cisplatin	Approved Investigational	PYCR1	5831	upregulated	Cisplatin results in increased expression of PYCR1 mRNA	17q25.3	A20427
Cisplatin	Approved Investigational	PYGL	5836	downregulated	Cisplatin results in decreased expression of PYGL mRNA	14q22.1	A20427
Cisplatin	Approved Investigational	QDPR	5860	upregulated	Cisplatin results in increased expression of QDPR mRNA	4p15.32	A22203
Cisplatin	Approved Investigational	RAB28	9364	downregulated	Cisplatin results in decreased expression of RAB28 mRNA	4p15.33	A22211
Cisplatin	Approved Investigational	RAB31	11031	upregulated	Cisplatin results in increased expression of RAB31 mRNA	18p11.22	A20427
Cisplatin	Approved Investigational	RAD51C	5889	downregulated	Cisplatin results in decreased expression of RAD51C mRNA	17q22	A21499
Cisplatin	Approved Investigational	RAI14	26064	downregulated	Cisplatin results in decreased expression of RAI14 mRNA	5p13.2	A22204
Cisplatin	Approved Investigational	RAP2B	5912	downregulated	Cisplatin results in decreased expression of RAP2B mRNA	3q25.2	A21499
Cisplatin	Approved Investigational	RARA	5914	downregulated	Cisplatin results in decreased expression of RARA mRNA	17q21.2	A20427
Cisplatin	Approved Investigational	RASA3	22821	downregulated	Cisplatin results in decreased expression of RASA3 mRNA	13q34	A22204
Cisplatin	Approved Investigational	RBM18	92400	upregulated	Cisplatin results in increased expression of RBM18 mRNA	9q33.2	A22204
Cisplatin	Approved Investigational	RBM34	23029	downregulated	Cisplatin results in decreased expression of RBM34 mRNA	1q42.3	A21499

Displaying entries 31951 - 31975 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability